PUBLISHER: IMARC | PRODUCT CODE: 1986520
PUBLISHER: IMARC | PRODUCT CODE: 1986520
The global iodine market size reached USD 1,091.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,606.9 Million by 2034, exhibiting a growth rate (CAGR) of 4.26% during 2026-2034. The growing demand for iodine in the healthcare industry for medical imaging and treatments is accelerating the market.
Growing Adoption of Iodine-Based Therapies
The increasing recognition of iodine's therapeutic potential in treating various health conditions, particularly thyroid-related disorders, is driving iodine market growth. In addition, iodine's role in targeting specific cells, along with ongoing research, is expanding its use in medical treatments, thereby contributing to broader healthcare applications and market demand. For instance, in March 2024, the American Oncology Institute at Imphal's Babina Specialty Hospital introduced iodine therapy, a groundbreaking treatment for thyroid cancer . This therapy utilizes radioactive iodine to target cancerous cells, thereby marking a significant advancement in cancer care for Northeast India.
Rising Demand for Iodized Salt Education
Public health campaigns focusing on the importance of iodine in preventing deficiencies are driving demand for iodized salt. Furthermore, educating populations about the benefits of iodine in diets helps combat iodine deficiency disorders, boosting the adoption of iodized salt and related products, especially in regions with higher health awareness. For instance, in October 2024, ITC Ltd partnered with the Institute of Global Development and launched the Aashirvaad Smart India Program to combat iodine deficiency disorders (IDD). The initiative aims to educate 5 lakh people on iodized salt's health benefits.
Advancements in AI-powered Healthcare Solutions
The integration of AI technologies into iodine-related healthcare processes is transforming clinical efficiency. In contrast, AI-powered platforms streamline utilization management, automate workflows, and enhance revenue integrity for healthcare providers, which is leading to improved resource management and driving the iodine demand in healthcare technology applications, thereby elevating the iodine market share. For instance, in February 2024, Iodine Software launched AwareUM, an AI-powered solution that streamlines utilization management for hospitals. It enhances clinical productivity, automates processes, and strengthens revenue integrity, built on Iodine's CognitiveML engine, and transforming mid-revenue cycle management for healthcare providers across the U.S.
Caliche ore currently holds the largest iodine market share
Caliche ore exhibits a clear dominance in the market as a primary source, with over 60% of the world's iodine production. For instance, SQM's caliche operations in Chile contribute significantly to global iodine supply through innovative extraction processes.
Organic compounds currently dominate the market
Organic compounds dominate the market due to their extensive use in pharmaceuticals and medical imaging. For instance, BASF's launch of iodized contrast agents highlights the growing demand for organic iodine-based products in healthcare.
X-ray contrast media currently dominates the market
X-ray contrast media leads the market, especially iodine-based types, due to its superior imaging clarity in procedures like angiography. For example, Bracco launched "Iomeron," a widely used iodine contrast agent enhancing diagnostic accuracy.
Europe currently dominates the market
The market outlook report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe accounted for the largest iodine market share.
Europe dominates the market due to its strong demand in the pharmaceutical and chemical industries. In contrast, the region's well-established healthcare sector, particularly in countries like Germany and France, drives iodine consumption for medical treatments and nutritional supplements. For example, Iofina, a leading iodine manufacturer expanded its presence in Europe by increasing iodine extraction from brine solutions. Furthermore, this growth is further supported by rising iodine applications in agriculture and food fortification, thereby boosting the region's market dominance.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all market companies have also been provided. Some of the key players in the market include:
()